Table of Contents

company-logo

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Dividend Announcement

• AbCellera Biologics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on AbCellera Biologics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

AbCellera Biologics Dividend History

AbCellera Biologics Dividend Yield

AbCellera Biologics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing AbCellera Biologics stock? Use our calculator to estimate your expected dividend yield:

AbCellera Biologics Financial Ratios

P/E ratio-4.95
PEG ratio0.05
P/B ratio0.81
ROE-15.73%
Payout ratio0.00%
Current ratio9.34
Quick ratio9.34
Cash Ratio1.59

AbCellera Biologics Dividend FAQ

Does AbCellera Biologics stock pay dividends?
AbCellera Biologics does not currently pay dividends to its shareholders.
Has AbCellera Biologics ever paid a dividend?
No, AbCellera Biologics has no a history of paying dividends to its shareholders. AbCellera Biologics is not known for its dividend payments.
Why doesn't AbCellera Biologics pay dividends?
There are several potential reasons why AbCellera Biologics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will AbCellera Biologics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While AbCellera Biologics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is AbCellera Biologics a dividend aristocrat?
AbCellera Biologics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is AbCellera Biologics a dividend king?
AbCellera Biologics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is AbCellera Biologics a dividend stock?
No, AbCellera Biologics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy AbCellera Biologics stocks?
To buy AbCellera Biologics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy AbCellera Biologics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.